Antifibrotic therapy of liver cirrhosis, with special reference to primary biliary cirrhosis: promises and limitations.
Jansen
P L
PL
Division of Hepatogastroenterology, Academic Medical Centre, Amsterdam, Netherlands.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D014580:Ursodeoxycholic Acid